SSA
VTYX

Schonfeld Strategic Advisors’s Ventyx Biosciences VTYX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,027
Closed -$361K – 2721
2025
Q4 		$361K Sell
40,027
-174,162
-81% -$1.3M ﹤0.01% 1510
2025
Q3 		$666K Buy
+214,189
New +$567K ﹤0.01% 1559
2024
Q4 		– Sell
-432,700
Closed -$943K – 2430
2024
Q3 		$943K Sell
432,700
-721,241
-63% -$1.66M 0.01% 1180
2024
Q2 		$2.67M Sell
1,153,941
-1,213,059
-51% -$5.04M 0.02% 782
2024
Q1 		$13M Buy
2,367,000
+2,171,200
+1,109% +$9.93M 0.09% 283
2023
Q4 		$484K Buy
+195,800
New +$1.86M ﹤0.01% 1298
2022
Q4 		– Sell
-12,700
Closed -$443K – 3051
2022
Q3 		$443K Buy
+12,700
New +$281K ﹤0.01% 1834

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Schonfeld Strategic Advisors's VTYX Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 40,027 shares — an estimated $361K sold.

Schonfeld Strategic Advisors first reported a position in VTYX in Q3 2022 and held it in 7 quarters. The position peaked at $13M in Q1 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 40,027 Ventyx Biosciences shares in Q1 2026, an estimated $361K.
  • Schonfeld Strategic Advisors first reported a position in Ventyx Biosciences in Q3 2022 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's Ventyx Biosciences position peaked at $13M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.